Importance of the ankle-brachial pressure index in the diagnosis of coronary artery disease in women with diabetes without anginal pain

Circulation Journal

Volumn 75, Issue 9, 2011, Pages 2206-2212

  Igarashi, Yuko ^a   Chikamori, Taishiro ^a   Hida, Satoshi ^a   Tanaka, Hirokazu ^a   Shiba, Chie ^a   Usui, Yasuhiro ^a   Hatano, Tuguhisa ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Ankle brachial pressure index; Coronary artery disease; Diabetes mellitus; Myocardial perfusion imaging; Women

Indexed keywords

AGED; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD PRESSURE MEASUREMENT; CIGARETTE SMOKING; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DIAGNOSTIC TEST; ELECTROCARDIOGRAPHY; FEMALE; HEART SCINTISCANNING; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; RETROSPECTIVE STUDY; RISK ASSESSMENT;

AGED; ANKLE BRACHIAL INDEX; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 80052149689     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1287     Document Type: Article

References (33)

1. Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeifer EA, et al. Coronary atherosclerosis in diabetes mellitus: A population-based autopsy study. J Am Coll Cardiol 2002; 40: 946-953.
2. Khaleeli E, Peters SR, Bobrowsky K, Oudiz RJ, Ko JY, Budoff MJ. Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease: Implications for management. Am Heart J 2001; 141: 637-644.
3. Nesto RW, Watson FS, Kowalchuk GJ, Zarich SW, Hill T, Lewis SM, et al. Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: Assessment by dipyridamole thallium-201 scintigraphy. Am Heart J 1990; 120: 1073-1077.
4. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234.
5. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging 2008; 35: 319-328.
6. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care 2004; 27: 1954-1961.
7. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW. Detection of silent myocardial ischemia in diabetes mellitus (comments). Am J Cardiol 1991; 67: 1073-1078.
8. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD Study: A Randomized Controlled Trial. JAMA 2009; 301: 1547-1555.
9. Igarashi Y, Chikamori T, Tomiyama H, Usui Y, Hida S, Tanaka H, et al. Diagnostic value of simultaneous brachial and ankle blood pressure measurements for the extent and severity of coronary artery disease as assessed by myocardial perfusion imaging. Circ J 2005; 69: 237-242.
10. Feinstein SB, Voci P, Pizzuto F. Noninvasive surrogate markers of atherosclerosis. Am J Cardiol 2002; 89: 31C-43C.
11. Yamashina A, Tomiyama H, Takeda T, Tsuda H, Arai T, Hirose K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
12. The Committee of Japan Diabetes Society for the diagnostic criteria of diabetes mellitus. Report of the committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus. J Japan Diab Soc 1999; 42: 385-404.
13. Papamichael CM, Lekakis JP, Stamatelopoulos KS, Papaioannou TG, Alevizaki MK, Cimponeriu AT, et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 2000; 86: 615-618.
14. Greenland P, Abrams J, Aurigemmab GP, Bond MG, Clark LT, Criqui MH, et al. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention noinvasive test of atherosclerotic burden. Circulation 2000; 101: e16-e22.
15. Heo J, Kegel J, Iskandrian AS, Cave V, Iskandrian BB. Comparison of same-day protocols using technetium-99m-sestamibi myocardial imaging. J Nucl Med 1992; 33: 186-191.
16. Fletcher GF, Balady GJ, Froelicher VF, Hartley LH, Haskell WL, Pollock ML. Exercise standards for testing and training: A statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 1694-1740.
17. Hida S, Chikamori T, Hirayama T, Usui Y, Yanagisawa H, Morishima T, et al. Beneficial effect of coronary artery bypass grafting as assessed by quantitative gated single-photon emission computed tomography. Circ J 2003; 67: 499-504.
18. Yanagisawa H, Chikamori T, Tanaka N, Hatano T, Morishima T, Hida S, et al. Correlation between thallium-201 myocardial perfusion defects and the functional severity of coronary artery stenosis as assessed by pressure-derived myocardial fractional flow reserve. Circ J 2002; 66: 1105-1109.
19. Berman DS, Hachamovitch R, Kiat H, Cohe I, Cabico JA, Fan PW, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 639-647.
20. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single-photon emission computed tomography. Circulation 2003; 107: 2900-2907.
21. Nakajima K, Yamasaki Y, Kusuoka H, Izumi T, Kashiwagi A, Kawamori R, et al. Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: A 1-year interim report of a JACCESS 2 investigation using myocardial perfusion imaging. Eur J Nucl Med Mol Imaging 2009; 36: 2049-2057.
22. Slomka PJ, Nishina H, Berman DS, Kang X, Friedman JD, Hayes SW, et al. Automatic quantification of myocardial perfusion stress-rest change: A new measure of ischemia. J Nucl Med 2004; 45: 183-191.
23. Inoguchi T, Yamashita T, Umeda F, Mihara H, Nakagaki O, Takada K, et al. High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 2000; 47: 37-44.
24. Rutter M, Wahid S, McComb J, Marshall S. Significance of silent ischemia and micro albuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 2002; 40: 56-61.
25. Faglia E, Favales F, Calia P, Paleari F, Segalini G, Gamba PL, et al. Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 2002; 25: 2032-2036.
26. Chikamori T, Vinik AI, Vidovich MI. Screening for asymptomatic coronary artery disease in patients with type 2 diabetes. JAMA 2009; 302: 735-737.
27. Sakamoto S, Yokoyama N, Tamori Y, Akutsu K, Hashimoto H, Takeshita S. Patients with peripheral artery disease who complete 12-week supervised exercise training program show reduced cardiovascular mortality and morbidity. Circ J 2009; 73: 167-173.
28. Wijins W, Kolh P, Danchin N, Mario CD, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization; The task force on myocardial revascularization of European Society of Cardiology (ESC) and the European Association for Cardio-thoracic Surgery. Eur Heart J 2010; 31: 2501-2555.
29. Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ; American Diabetes Association. Screening for coronary artery disease in patients with diabetes. Diabetes Care 2007; 30: 2729-2736.
30. Beller GA. Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type2 diabetic patients: Is it appropriate and cost-effective? J Am Coll Cardiol 2007; 49: 1918-1923.
31. Matsuo S, Nakajima K, Yamasaki Y, Kashiwagi A, Nishimura T. Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese asymptomatic patients with type 2 diabetes. Circ J 2010; 74: 1916-1921.
32. Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol 2005; 45: 43-49.
33. Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 2010; 304: 1350-1357.